[cs_content][cs_section parallax="false" style="margin: 0px;padding: 45px 0px;"][cs_row inner_container="true" marginless_columns="false" style="margin: 0px auto;padding: 0px;"][cs_column fade="false" fade_animation="in" fade_animation_offset="45px" fade_duration="750" type="1/1" style="padding: 0px;"][cs_text]How can Glucose, Insulin, and Potassium save your life? Glucose, Insulin, and Potassium is also known as GIK is a simple solution to saving anyone suffering from Acute Myocardial Infarction (AMI). Heart attacks is an AMI. AMI is the leading cause of death in America. There are over 500,000 deaths due to heart attacks every year and less than 10% survive. GIK is a new solution under study that is known to help anyone going through a cardiac event.[/cs_text][x_custom_headline level="h2" looks_like="h3" accent="false"]What is Acute Myocardial Infarction (AMI)?[/x_custom_headline][cs_text]An Acute Myocardial Infarction (AMI) is equivalent to a heart attack. What this means are the coronary arteries that feed blood to the heart tissue becomes blocked or has an occlusion. The flow of blood is limited or completely obstructed to feed the cardiac tissues. When this happens, part of the heart’s tissues starts to die. The patient will show signs of the tightness of the chest, pain in the chest which may radiate down the arm of up into jaw. Some patients feel indigestion, fatigue, and persistant back pains. If you like to learn more about AMI, check out The National Library of Medicine.[/cs_text][x_custom_headline level="h2" looks_like="h3" accent="false"]The ECLA study [/x_custom_headline][cs_text]The Estudio Cardiologico Latinoamerica (ECLA) did a random study on a variety of AMI patients who were treated with GIK solution. The study group was through one year and had 264 participants. 133 patients with an AMI were treated with GIK solution, and the other 135 patients were given a placebo. Out of the 133 patients receiving treatment depending on the dose, they received would determine the percentage of an AMI recovery. Those that received a low dose during an AMI occurance had a 28% decreased mortality rate versus the placebo group. Those that had a high dose of GIK during an AMI occurance had up to a 48% decrease in mortality rate than the placebo group. The result of this study is comparable to the previous meta-analysis of GIK solution.[/cs_text][x_custom_headline level="h2" looks_like="h3" accent="false"]The controversy of GIK study.[/x_custom_headline][cs_text]In the past 40 years, there are numerous studies of the use of GIK, and since it is currently used in cardiac surgical treatments, it is not recommended for infusion of AMI. The reason is from an early meta-analysis that found flaws from the length of time to infuse from the onset of AMI till treatment. Another flaw is the number of participants and randomness of patients which limited accual data of results. The studies have had trouble keeping a controlled setting since AMI’s are acute and in emergency settings. The requirement is more studies should be conducted with the use of GIK with larger groups over time.[/cs_text][x_custom_headline level="h2" looks_like="h3" accent="false"]The significants of GIK for today[/x_custom_headline][cs_text]When a person is suffering from an AMI or heart attack, there are currently good and tested treatments to resolve and partially correct the issue. The current treatment for an AMI is giving a patient one dose of adult asprin or two baby asprin. Have an AED and if needed to be ready to perform CPR. GIK is a potential solution in treating patients with AMI and with further study, we believe that glucose insulin and potassium if given early will correct the restricted blood flow to the heart and heal the damaged tissue.[/cs_text][/cs_column][/cs_row][/cs_section][/cs_content]
